All figures shown in the chart above are for the trailing 12 month (TTM) period
Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 11%.
The primary driver behind last 12 months revenue was the Hong Kong, China segment contributing a total revenue of CN¥3.88b (33% of total revenue). Notably, cost of sales worth CN¥7.32b amounted to 62% of total revenue thereby underscoring the impact on earnings. The largest operating expense was Research & Development (R&D) costs, amounting to CN¥1.57b (45% of total expenses). Over the last 12 months, the company's earnings were enhanced by non-operating gains of CN¥317.5m. Explore how 6969's revenue and expenses shape its earnings.
Looking ahead, revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 6.3% growth forecast for the Tobacco industry in Asia.
Performance of the market in Hong Kong.
The company's shares are up 24% from a week ago.
Just as investors must consider earnings, it is also important to take into account the strength of a company's balance sheet. We've done some analysis and you can see our take on Smoore International Holdings' balance sheet.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.